Iron Loading Selectively Increases Hippocampal Levels of Ubiquitinated Proteins and Impairs Hippocampus-Dependent Memory

Molecular Neurobiology

Volumn 53, Issue 9, 2016, Pages 6228-6239

  Figueiredo, Luciana Silva ^a   de Freitas, Betânia Souza ^a   Garcia, Vanessa Athaíde ^a   Dargél, Vinícius Ayub ^a   Köbe, Luiza Machado ^a   Kist, Luiza Wilges ^a   Bogo, Maurício Reis ^a   Schröder, Nadja ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Iron; Memory; Neurodegenerative disorders; Ubiquitin proteasome system; proteasome subunits

Indexed keywords

IRON; PROTEASOME; PROTEASOME BETA 1; PROTEASOME BETA 2; PROTEASOME BETA 5; UBIQUITINATED PROTEIN; UNCLASSIFIED DRUG; POLYUBIQUITIN;

ADULT; AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CONDITIONING; CONTROLLED STUDY; DEGENERATIVE DISEASE; EMOTION; FEMALE; HIPPOCAMPUS; MALE; MEMORY DISORDER; NEWBORN; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PROTEIN EXPRESSION; RAT; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MEMORY; METABOLISM; PROTEIN SUBUNIT; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IRON; MEMORY; POLYUBIQUITIN; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; RATS, WISTAR; UBIQUITINATED PROTEINS;

EID: 84946780170     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9514-6     Document Type: Article

References (54)

1. Wong E, Cuervo AM (2011) Integration of clearance mechanisms: the proteasome and autophagy. Cold Spring Harb Perspect Biol 2:a006734
2. Ciechanover A, Brundin P (2003) The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40:427–446
3. Heinemeyer W, Fischer M, Krimmer T, Stachon U, Wolf DH (1997) The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing. J Biol Chem 272:25200–25209
4. Voges D, Zwickl P, Baumeister W (1999) The 26 S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68:1015–1068
5. Bochtler M, Ditzel L, Groll M, Hartmann C, Huber R (1999) The proteasome. Annu Rev Biophys Biomol Struct 28:295–317
6. Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425–479
7. Yao X, Liu J, McCabe JT (2008) Alterations of cerebral cortex and hippocampal proteasome subunit expression and function in a traumatic brain injury rat model. J Neurochem 104:353–363
8. Jadhav T, Wooten MW (2009) Defining an embedded code for protein ubiquitination. J Proteomics Bioinform 2:316–333
9. Hegde AN, Upadhya SC (2011) Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease. Biochim Biophys Acta 1809:128–140
10. Keck S, Nitsch R, Grune T, Ullrich O (2003) Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer’s disease. J Neurochem 85:115–122
11. Keller JN, Hanni KB, Markesbery WR (2000) Impaired proteasome function in Alzheimer’s disease. J Neurochem 75:436–439
12. Lopez-Salon M, Morelli L, Castano EM, Soto EF, Pasquini JM (2000) Defective ubiquitination of cerebral proteins in Alzheimer’s disease. J Neurosci Res 62:302–310
13. Gavilán MP, Vela J, Castaño A, Ramos B, del Río JC, Vitorica J, Ruano D (2006) Cellular environment facilitates protein accumulation in aged rat hippocampus. Neurobiol Aging 27:973–982
14. Keller JN, Hanni KB, Markesbery WR (2000) Possible involvement of proteasome inhibition in aging: implications for oxidative stress. Mech Ageing Dev 113:61–70
15. Bedford L, Hay D, Devoy A et al (2008) Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies. J Neurosci 28:8189–8198
16. Betarbet R, Canet-Aviles RM, Sherer TB et al (2006) Intersecting pathways to neurodegeneration in Parkinson’s disease: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin-proteasome system. Neurobiol of Dis 22:404–420
17. Seo H, Sonntag KC, Kim W, Cattaneo E, Isacson O (2007) Proteasome activator enhances survival of Huntington’s disease neuronal model cells. PloS ONE 2(2), e238
18. Schipper HM (2012) Neurodegeneration with brain iron accumulation—clinical syndromes and neuroimaging. Biochim Biophys Acta 1822:350–360
19. Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron brain ageing and neurodegenerative disorders. Lancet Neurol 13:1045–1060
20. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5(11):863–873
21. Kell DB (2010) Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, prions, bactericides, chemical toxicology and others as examples. Arch Toxicol 84:825–889
22. Schröder N, Figueiredo L, de Lima MN (2013) Role of brain iron accumulation in cognitive dysfunction: evidence from animal models and human studies. J Alzheimers Dis 34:797–812
23. Schröder N, Fredriksson A, Vianna MR, Roesler R, Izquierdo I, Archer T (2001) Memory deficits in adult rats following post natal iron administration. Behav Brain Res 124(1):77–85
24. De Lima MN, Polydoro M, Laranja DC, Bonatto F, Bromberg E, Moreira JC, Dal-Pizzol F, Schröder N (2005) Recognition memory impairment and brain oxidative stress by postnatal iron administration. Eur J Neurosci 21:2521–2528
25. Da Silva VK, De Freitas BS, Da Silva AD et al (2014) Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection. Mol Neurobiol 49:222–233
26. Budni P, de Lima MN, Polydoro M, Moreira JC, Schröder N, Dal-Pizzol F (2007) Antioxidant effects of selegiline in oxidative stress induced by iron neonatal treatment in rats. Neurochem Res 32:965–972
27. Dal-Pizzol F, Klamt F, Frota ML et al (2001) Neonatal iron exposure induces oxidative stress in adult Wistar rat. Brain Res Dev 130:109–114
28. Miwa CP, de Lima MN, Scalco F et al (2011) Neonatal iron treatment increases apoptotic markers in hippocampal and cortical areas of adult rats. Neurotox Res 19:527–535
29. Fernandez LL, de Lima MN, Scalco F, Vedana G, Miwa C, Hilbig A, Vianna MR, Schröder N (2011) Early post-natal iron administration induces astroglial response in the brain of adult and aged rats. Neurotox Res 20:193–199
30. Fagherazzi EV, Garcia VA, Maurmann N et al (2011) Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders. Psychopharmacology 219(4):1133–1140
31. Silva PF, Garcia VA, Da Dornelles AS et al (2012) Memory impairment induced by brain iron overload is accompanied by reduced H3K9 acetylation and ameliorated by sodium butyrate. Neuroscience 200:42–49
32. Taylor EM, Morgan EH (1990) Developmental changes in transferrin and iron uptake by the brain in the rat. Brain Res Dev Brain Res 55:35–42
33. Taylor EM, Crowe A, Morgan EH (1991) Transferrin and iron uptake by the brain: effects of altered iron status. J Neurochem 57:1584–1592
34. Izquierdo I, Medina JH (1997) Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol Learn Mem 68:285–316
35. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
36. Pilchova I, Klacanova K, Chomova M, Tatarkova Z, Dobrota D, Racay P (2015) Possible contribution of proteins of Bcl-2 family in neuronal death following transient global brain ischemia. Cell Mol Neurobiol 35:23–31
37. Bhat KP, Yan S, Wang CE, Li S, Li XJ (2014) Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A. Proc Natl Acad Sci U S A 111:5706–5711
38. Bonefeld BE, Elfving B, Wegener G (2008) Reference genes for normalization: a study of rat brain tissue. Synapse 62:302–309
39. Bustin SA, Benes V, Garson J et al (2013) The need for transparency and good practices in the qPCR literature. Nat Methods 10:1063–1067
40. Rodrigue KM, Daugherty AM, Haacke EM, Raz N (2013) The role of hippocampal volume in age-related differences in memory. Cereb Cortex 23(7):1533–1541
41. Figueiredo LS, Dornelles AS, Petry FS et al (2015) Two waves of proteasome-dependent protein degradation in the hippocampus are required for recognition memory consolidation. Neurobiol Learn Mem 120:1–6
42. Hegde AN, Inokuchi K, Pei W et al (1997) Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in aplysia. Cell 89:115–126
43. Jarome TJ, Werner CT, Kwapis JL, Helmstetter FJ (2011) Activity dependent protein degradation is critical for the formation and stability of fear memory in the amygdale. PLoS ONE 6:e24349
44. Reis DS, Jarome TJ, Helmstetter FJ (2013) Memory formation for trace fear conditioning requires ubiquitin-proteasome mediated degradation in the prefrontal cortex. Front Behav Neurosci 7:1–7
45. Lopez-Salon M, Alonso M, Vianna MR, Viola H, Mello e Souza T, Izquierdo I, Pasquini JM, Medina JH (2001) The ubiquitin-proteasome cascade is required for mammalian long-term memory formation. Eur J Neurosci 14:1820–1826
46. Zhu W, Li X, Xie W, Luo F, Kaur D, Andersen JK, Jankovic J, Le W (2010) Genetic iron chelation protects against proteosome inhibition-induced dopamine neuron degeneration. Neurobiol Dis 37:307–313
47. Gavilán MP, Pintado C, Gavilán E, Jiménez S, Ríos RM, Vitorica J, Castaño A, Ruano D (2009) Dysfunction of the unfolded protein response increases neurodegeneration in aged rat hippocampus following proteasome inhibition. Aging Cell 8:654–665
48. Pintado C, Gavilán M, Gavilán E et al (2012) Lipopolysaccharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration induced by proteasome inhibition in rat hippocampus. J Neuroinflammation 9:87
49. Nunziante M, Ackermann K, Dietrich K et al (2011) Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein. J Biol Chem 286:33942–33953
50. Hare DJ, Arora M, Jenkins NL, Finkelstein DI, Doble PA, Bush AI (2015) Is early-life iron exposure critical in neurodegeneration? Nat Rev Neurol 11:536–544
51. Keller JN, Dimayuga E, Chen Q, Thorpe J, Gee J, Ding Q (2004) Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int J Biochem Cell Biol 36:2376–2391
52. Zhu W, Xie W, Pan T et al (2007) Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators. FASEB J 21:3835–3844
53. Martinez-Vicente M, Sovak G, Cuervo AN (2005) Protein degradation and aging. Exp Gerontol 40:622–633
54. Giannini C, Kloβ A, Gohlke S, Mishto M, Nicholson TP, Sheppard PW, Kloetzel PM, Dahlmann B (2013) Poly-Ub-substrate-degradative activity of 26S proteasome is not impairment in the aging rat brain. Plos One 8(5):e64042